Risks and benefits of biologic therapy for inflammatory bowel diseases
AUTOR(ES)
D'Haens, Geert
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1942157Documentos Relacionados
- Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk?
- Inflammatory Bowel Diseases
- Risks and benefits of hormone replacement therapy: The evidence speaks
- Inflammatory Bowel Diseases and diet: an integrative review
- A role for proteinase-activated receptor–1 in inflammatory bowel diseases